Amendment to pre-order trial for Fluoroquinolone Products
Amendment to pre-order trial for Fluoroquinolone Products

Introduction
The pretrial schedule for the first bellwether trials involving Cipro and Avelox was amended to extend the non-expert fact discovery deadline until January 26, 2018. Fluoroquinolone or peripheral neuropathy lawsuits involving Avelox, Cipro, and Levaquin are a part of the multidistrict litigation 2642 in the U.S. District Court, District of Minnesota. January 19, 2018, is the deadline for completion of case-specific discovery for Avelox-only and Cipro-only cases. As of today, the bellwether trials begin from November 2018 for the Avelox-only cases and from March 4, 2019, for the Cipro-only cases
Latest News
NC to Get $150M to Boost Opioid Treatment, Recovery
North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid…